European Archives - Page 575 of 1232 - European Medical Journal

EMJ Reproductive Health 8.1 2022

Welcome to our latest issue of EMJ Reproductive Health. We are proud to share with you a collection of new and interesting reviews and research articles.

Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment

This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures

Interview Mausumi Das

Interview: Mausumi Das

EMJ team had the pleasure of interviewing two specialists: Mausumi Das, Consultant Gynaecologist and a Subspecialist in Reproductive Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, and Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

Are Reproductive Rights Progressing in the 21st Century?

In a live session at the European Society of Human Reproduction and Embryology (ESHRE) 38th Annual Meeting, a pertinent debate over reproductive rights in this millennium was held between Jennifer Merchant, University Panthéon-Assas Paris II, France, and Marleen Temmerman, Aga Khan University Hospital, Nairobi, Kenya.

Interview Signe Altmäe

Interview: Signe Altmäe

EMJ team had the pleasure of interviewing two specialists: Signe Altmäe Department of Biochemistry and Molecular Biology, University of Granada, Spain, and Division of Obstetrics and Gynaecology, Karolina Institutet, Stockholm, Sweden.

Editor's Pick: The Value of Serum Follicle-Stimulating Hormone in Predicting Successful Surgical Sperm Retrieval in Cases of Male Infertility: A Literature Review

Male factor aetiologies account for approximately 50% of infertility in couples, with azoospermia diagnosed in up to 15% of infertile males. The World Health Organization (WHO) semen analysis parameters are universally used and define azoospermia as an absence of spermatozoa identified in wet or centrifuged ejaculate samples.

ESHRE 2022 Abstract Highlights

The following highlights cover several innovative and thought-provoking abstracts from the 38th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), featuring topics such as artificial intelligence in fertility treatments, a potential biomarker for endometriosis, and the use of testosterone therapy in in vitro fertilisation.

Progesterone Resistance in Endometriosis

Endometriosis is characterised by the presence of endometrium-like tissue on the pelvis and other organs. Progesterone resistance due to suppressed progesterone receptor (PGR) expression and action is a general feature of endometriosis and is a cause of endometriosis-associated chronic pelvic pain, infertility, inflammatory disorders, and cancer.

Immediate Perinatal Outcome of Mothers with Maternal Near-Miss at Moi Teaching and Referral Hospital, Eldoret, Kenya

Improving maternal health has been a major concern worldwide. This is evident by maternal health being included in the Millennium Development Goals, with the goal of reducing maternal mortality by three-quarters by 2015, and now the Sustainable Development Goals, with targets set to reduce the global maternal mortality ratio to less than 70 per 100,000 live births.

Pharma in India

India, known by some as ‘the pharmacy of the world’, has a growing pharma reputation, but what has shaped this company’s ascension to pharmaceutical powerhouse status?